PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
Pill imprint PRASCO 327 has been identified as Phenylephrine and guaifenesin SR 30 mg / 900 mg.
Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 30 mg / 900 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PRASCO 327
- Strength:
- 30 mg / 900 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Prasco Laboratories
More about guaifenesin/phenylephrine
Consumer resources
- Guaifenesin/phenylephrine
- Guaifenesin/phenylephrine controlled-release tablets
- Guaifenesin/phenylephrine liquid
- Guaifenesin/phenylephrine suspension
- Guaifenesin/phenylephrine sustained-release capsules
- More (2) »
- Other brands: Entex LA, Deconex, Rescon-GG, Miraphen PE, More (24) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
